Ardent Health Partners, LLC (NYSE:ARDT) Receives $21.82 Consensus PT from Brokerages

Ardent Health Partners, LLC (NYSE:ARDT) has earned a consensus rating of “Buy” from the twelve brokerages that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating on the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $22.00.

Several research analysts have recently weighed in on ARDT shares. Royal Bank of Canada reissued an “outperform” rating and set a $23.00 price objective on shares of Ardent Health Partners in a report on Thursday, November 14th. Leerink Partners boosted their target price on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th. KeyCorp started coverage on Ardent Health Partners in a report on Friday, October 11th. They set an “overweight” rating and a $24.00 price target on the stock. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $20.00 price objective on shares of Ardent Health Partners in a report on Tuesday. Finally, Bank of America cut Ardent Health Partners from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th.

Ardent Health Partners Price Performance

Shares of NYSE:ARDT opened at $16.76 on Friday. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The stock has a 50-day simple moving average of $17.39. Ardent Health Partners has a fifty-two week low of $14.57 and a fifty-two week high of $20.72.

Institutional Trading of Ardent Health Partners

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. BNP Paribas Financial Markets purchased a new position in shares of Ardent Health Partners during the 3rd quarter valued at about $42,000. Financial Management Professionals Inc. bought a new stake in Ardent Health Partners during the 3rd quarter worth approximately $50,000. MetLife Investment Management LLC purchased a new position in Ardent Health Partners during the third quarter valued at approximately $135,000. Quadrature Capital Ltd purchased a new position in Ardent Health Partners during the third quarter valued at approximately $229,000. Finally, Barclays PLC bought a new position in shares of Ardent Health Partners in the third quarter worth approximately $385,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.